Latest Articles
Endometriosis: The painful condition affecting up to 1 in 10 Irish women - Donegal Daily
Endometriosis: The painful condition affecting up to 1 in 10 Irish women Donegal Daily
Published: April 13, 2026, 10:04 p.m.
'Sick of women being ignored' - Endometriosis meeting hears heartbreaking experiences - Donegal Daily
'Sick of women being ignored' - Endometriosis meeting hears heartbreaking experiences Donegal Daily
Published: April 13, 2026, 9:44 p.m.
Eiza González Says It Took ‘Decades’ to Get Diagnosed with PCOS, Endometriosis and Adenomyosis: ‘Years of Gaslighting’ - AOL.com
Eiza González Says It Took ‘Decades’ to Get Diagnosed with PCOS, Endometriosis and Adenomyosis: ‘Years of Gaslighting’ AOL.com
Published: April 13, 2026, 9:30 p.m.
BBC Host Naga Munchetty Opens Up About Suffering From ‘Evil Twin Sister Of Endometriosis’ - Health and Me
BBC Host Naga Munchetty Opens Up About Suffering From ‘Evil Twin Sister Of Endometriosis’ Health and Me
Published: April 13, 2026, 7:30 p.m.
BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial - BioSpace
BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial BioSpace
Published: April 13, 2026, 5:57 p.m.
Endometriosis: ‘I was vomiting green. It’s like cancer without being cancer.’ - Luxembourg Times
Endometriosis: ‘I was vomiting green. It’s like cancer without being cancer.’ Luxembourg Times
Published: April 13, 2026, 4 p.m.
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer - MedPage Today
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer MedPage Today
Published: April 13, 2026, 3:43 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
Published: April 13, 2026, 12:29 p.m.
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com
Published: April 13, 2026, 12:14 p.m.
Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal - Stock Titan
Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal Stock Titan
Published: April 13, 2026, 11:55 a.m.
Link copied to clipboard!